The Conversation

The Conversation

conversationThe Conversation US arose out of deep-seated concerns for the fading quality of our public discourse – and recognition of the vital role that academic experts can play in the public arena.

Independent and not-for-profit, it is part of a global network of newsrooms first launched in Australia in 2011. The Conversation began its US operations in 2014, and now also publishes in Canada, the UK, France, Indonesia, Africa, Spain as well as Australia.

The Conversation’s mission is particularly resonant in the U.S., where people universally sense that the country’s social fabric is strained and the common ground people share is shrinking.

Information always has been essential to democracy – a societal good, like clean water. But many now find it difficult to put their trust in the media. And with little consensus about what to believe, it only becomes harder to reach agreement with fellow citizens regarding what’s truthful.

The Conversation US seeks to be part of the solution to this problem.

The Conversation’s editorial process is deliberate and collaborative. Editors pay close attention to the news environment to identify the issues citizens are concerned about. They reach out to leading scholars across academia and work with them to unlock their knowledge for the broad public.

Through a Creative Commons license, we share Conversation US articles – at no charge to news organizations – across the geographic and ideological spectrum. We pay particular attention to strengthening news organizations that are severely under-resourced. The Associated Press distributes The Conversation US articles daily to thousands of newsrooms.read more>

Website URL: https://theconversation.com/us

How mRNA vaccines from Pfizer and Moderna work, why they're a breakthrough and why they need to be kept so cold

 Moderna’s new mRNA vaccine is almost 94.5% effective in large-scale trials.

JUSTIN TALLIS/AFP via Getty Images

 

Sanjay Mishra, Vanderbilt University

 

As the weather cools, the number of infections of the COVID-19 pandemic are rising sharply. Hamstrung by pandemic fatigue, economic constraints and political discord, public health officials have struggled to control the surging pandemic. But now, a rush of interim analyses from pharmaceutical companies Moderna and Pfizer/BioNTech have spurred optimism that a novel type of vaccine made from messenger RNA, known as mRNA, can offer high levels of protection by preventing COVID-19 among people who are vaccinated.

Twitter posts show that people are profoundly sad – and are visiting parks to cheer up

Joe Roman, University of Vermont and Taylor Ricketts, University of Vermont

The COVID-19 pandemic in the United States is the deepest and longest period of malaise in a dozen years. Our colleagues at the University of Vermont have concluded this by analyzing posts on Twitter. The Vermont Complex Systems Center studies 50 million tweets a day, scoring the “happiness” of people’s words to monitor the national mood. That mood today is at its lowest point since 2008 when they started this project.

Subscribe to this RSS feed
Banner 468 x 60 px